Hosted on MSN1mon
Eli Lilly is partnering with Ro to make it easier than ever to get Zepbound
instead of the usual auto-injector pen the drug comes in. Eli Lilly isn’t alone in adopting direct-to-consumer strategies. Pfizer (PFE) launched a similar service, PfizerforAll, this summer ...
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
invezz on MSN5mon
Weight-loss drug Zepbound: Eli Lilly offers 50% discount on 2.5 mg and 5 mg vials to meet demand
We are very confident with both the auto-injectors and the vials that we will be able to supply the needs in the US ...
pharmaphorum2d
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
If approved, the less burdensome version of Leqembi could be used to treat patients at home or in medical facilities, help Eisai and Biogen differentiate Leqembi from Eli Lilly's recently approved ...
Forbes28d
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest ... In this photo is a Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday ...